Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector

Archive ouverte

Lucifora, Julie | Salvetti, Anna | Marniquet, Xavier | Mailly, Laurent | Testoni, Barbara | Fusil, Floriane | Inchauspé, Aurore | Michelet, Maud | Michel, Marie-Louise | Levrero, Massimo | Cortez, Pierre | Baumert, Thomas F. | François-Loïc, Cosset | Challier, Cécile | Zoulim, Fabien | Durantel, David

Edité par CCSD ; Elsevier Masson -

International audience. Hepatitis B Virus (HBV) persists in infected hepatocytes as an episomal covalently-closed-circular DNA mini-chromosome, called cccDNA. As the main nuclear transcription template, HBV cccDNA is a key replication intermediate in the viral life cycle. Little is known about the mechanisms involved in its formation, maintenance and fate under antiviral therapies. This is mainly due to the lack of small immune-competent animal models able to recapitulate the entire HBV replication cycle, including formation of HBV cccDNA. Here we report that HBV cccDNA can be detected by Southern blot analyses in the liver of C57BL6 mice transduced with AAV-HBV. HBV cccDNA persists in the liver of these animals together with the AAV-HBV episome. We also set up a PCR strategy to distinguish the HBV cccDNA from the AAV-HBV episome. These suggest that the AAV-HBV/mouse model might be relevant to test drugs targeting HBV cccDNA regulation and persistence.

Suggestions

Du même auteur

Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanisms

Archive ouverte | Lucifora, Julie | CCSD

International audience. Background & Aims: Chronic co-infection with hepatitis B and D viruses (HBV and HDV) leads to the most aggressive form of chronic viral hepatitis. Here, we aimed at elucidating the molecu...

Hepatitis B virus Core protein nuclear interactome identifies SRSF10 as a host RNA-binding protein restricting HBV RNA production

Archive ouverte | Chabrolles, Hélène | CCSD

International audience. Despite the existence of a preventive vaccine, chronic infection with Hepatitis B virus (HBV) affects more than 250 million people and represents a major global cause of hepatocellular carcin...

Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes

Archive ouverte | Lucifora, Julie | CCSD

International audience. Current therapies for chronic hepatitis B virus (HBV) infections are effective at decreasing the viral load in serum, but do not lead to viral eradication. Recent studies highlighted the ther...

Chargement des enrichissements...